The US government is pressuring states to halt funding for puberty blockers for children and follow the UK’s Cass Review.
The Center for Medicare and Medicaid Services (CMS), which provides health coverage to more than 160 million Americans, urged directors to adopt the findings of the report, which concluded children who think they are transgender should not be rushed into treatment they may regret.
In a letter sent to medical directors, seen by The Telegraph, the agency said that Britain has “diverged” from the United States and that the National Health Service’s new approach is more effective.
